Glytylus MP 1mg/500mg/15mg Tablet ER
Marketer
Capsutab Drugs Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glytylus MP 1mg/500mg/15mg Tablet ER
Metformin/Pioglitazone/Sitagliptin extended-release tablets (1mg/500mg/15mg) are a triple-combination therapy managing blood glucose in adults with type 2 diabetes. This medication complements diet and exercise to enhance glycemic control. It improves insulin sensitivity and glucose uptake, thus reducing blood sugar. Dosage and frequency should strictly adhere to your physician's instructions. Administer with food to minimize gastrointestinal discomfort. If a dose is missed, take it immediately unless the next dose is imminent; in that case, omit the missed dose. Never double the dose. Overdosage risks dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals elevates hypoglycemia risk; regular blood glucose monitoring is essential. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician before use. Renal function will be assessed before prescription. Limit alcohol consumption as it may intensify side effects.
Primary Ingredients of Glytylus MP 1mg/500mg/15mg Tablet ER
No text was provided to rewrite.
Uses of Glytylus MP 1mg/500mg/15mg Tablet ER
Managing Type 2 Diabetes
Major Benefits of Glytylus MP 1mg/500mg/15mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glytylus MP 1mg/500mg/15mg Extended-Release tablet whole; do not alter its physical form. Administer this medicine with food.
Common Side effects of Glytylus MP 1mg/500mg/15mg Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glytylus MP 1mg/500mg/15mg Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the Glytylus MP 1mg/500mg/15mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Take this medication with food.
How Glytylus MP 1mg/500mg/15mg Tablet ER works:
Glytylus MP 1mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple therapy offers enhanced blood sugar management when monotherapy or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Glytylus MP 1mg/500mg/15mg extended-release tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Glytylus MP tablets (1mg/500mg/15mg) may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glytylus MP tablets (1mg/500mg/15mg) are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Glytylus MP 1mg/500mg/15mg Extended-Release tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Glytylus MP 1mg/500mg/15mg Extended-Release tablets are contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Glytylus MP 1mg/500mg/15mg Extended-Release tablets cautiously, as dose modification may be necessary. Consult a physician for guidance. Glytylus MP 1mg/500mg/15mg Extended-Release tablets are contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glytylus MP 1mg/500mg/15mg Tablet ER :
Should you forget a Glytylus MP 1mg/500mg/15mg Extended-Release Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glytylus MP 1mg/500mg/15mg Tablet ER
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently